IMPAX LABORATORIES INC's ticker is IPXL and the CUSIP is 45256B101.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $366,000 | +14.7% | 18,837 | -1.6% | 0.01% | +25.0% |
| Q4 2017 | $319,000 | -18.0% | 19,152 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $389,000 | +26.3% | 19,152 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $308,000 | +27.3% | 19,152 | 0.0% | 0.00% | +33.3% |
| Q1 2017 | $242,000 | -4.7% | 19,152 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $254,000 | -75.7% | 19,152 | -56.6% | 0.00% | -76.9% |
| Q3 2016 | $1,046,000 | -56.0% | 44,152 | -46.5% | 0.01% | -13.3% |
| Q2 2016 | $2,378,000 | +80.0% | 82,486 | +100.0% | 0.02% | -11.8% |
| Q1 2016 | $1,321,000 | -15.5% | 41,243 | +12.8% | 0.02% | -19.0% |
| Q4 2015 | $1,564,000 | +44.5% | 36,567 | +19.0% | 0.02% | +50.0% |
| Q3 2015 | $1,082,000 | -23.3% | 30,721 | 0.0% | 0.01% | -17.6% |
| Q2 2015 | $1,411,000 | -2.0% | 30,721 | 0.0% | 0.02% | 0.0% |
| Q1 2015 | $1,440,000 | +48.0% | 30,721 | 0.0% | 0.02% | +70.0% |
| Q4 2014 | $973,000 | +105.3% | 30,721 | +53.6% | 0.01% | +100.0% |
| Q3 2014 | $474,000 | -21.0% | 20,000 | 0.0% | 0.01% | -16.7% |
| Q2 2014 | $600,000 | +41.8% | 20,000 | +25.0% | 0.01% | 0.0% |
| Q1 2014 | $423,000 | – | 16,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 730,817 | $21,062,000 | 7.59% |
| Hound Partners | 6,757,558 | $194,753,000 | 5.18% |
| Aravt Global | 2,232,500 | $64,341,000 | 4.78% |
| Asymmetry Capital Management, L.P. | 70,235 | $2,024,000 | 3.71% |
| UNIVERSITY OF NOTRE DAME DU LAC | 66,091 | $1,905,000 | 1.80% |
| Orbimed Advisors | 5,886,700 | $169,655,000 | 1.77% |
| Pennant Capital Management, LLC | 1,949,569 | $56,187,000 | 1.44% |
| SECTOR GAMMA AS | 233,934 | $6,742,000 | 1.28% |
| Tygh Capital Management, Inc. | 137,190 | $3,954,000 | 1.11% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 555,086 | $15,998,000 | 0.93% |